The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Screening for intrinsic and acquired resistance mutations to anti-EGFR in real-world MSS colorectal cancer data.
 
Matthew Maxwell
Employment - Tempus
 
Stamatina Fragkogianni
Employment - Tempus AI, Inc.
Stock and Other Ownership Interests - Tempus AI, Inc.
 
Michelle Stein
Employment - Tempus
Stock and Other Ownership Interests - Tempus
Patents, Royalties, Other Intellectual Property - Tempus
Travel, Accommodations, Expenses - Tempus
 
Radia Johnson
Employment - Tempus, Novo Nordisk, Gilead Sciences
Stock and Other Ownership Interests - Tempus, Novo Nordisk, Gilead Sciences
Patents, Royalties, Other Intellectual Property - Tempus
 
Van Morris
Consulting or Advisory Role - Abbvie; BioNTech SE; Bristol-Myers Squibb/Celgene; Exelixis; GlaxoSmithKline; Incyte; Pfizer
Research Funding - Bicara Therapeutics (Inst); BioNTech (Inst); Bristol-Myers Squibb (Inst); Pfizer (Inst)
 
Halla Nimeiri
Employment - Northwestern Medicine; Tempus AI
Stock and Other Ownership Interests - Abbvie; Tempus AI
 
Andrew Sedgewick
Employment - Tempus
Stock and Other Ownership Interests - Tempus
 
Scott Kopetz
Stock and Other Ownership Interests - Frontier Medicines; Lutris; Navire
Consulting or Advisory Role - Alentis Therapeutics; AmMax Bio; Arcus Biosciences; AstraZeneca; AVEO; BeiGene; BioNTech SE; Boehringer Ingelheim; Bristol-Myers Squibb/Medarex; Carina Biotech; Clasp Therapeutics; Cytovation; Dewpoint Therapeutics; EMD Serono; Erasca, Inc; Flame Biosciences; Frontier Medicines; Genentech; Harbinger Oncology, Inc; Ikena Oncology; Iterion Therapeutics; Kivu Biosciences; Marengo Therapeutics; Pfizer; Regeneron; Roche; SageMedic; SERVIER; Shionogi; T-Cypher Bio; Tachyon Therapeutics; Transcode; XAIRA Therapeutics; Zentalis; Zentalis
Research Funding - Boehringer Ingelheim; EMD Serono; Genentech; Pfizer; Roche; Zentalis
 
Justin Guinney
Employment - Tempus AI, Inc
Consulting or Advisory Role - AstraZeneca
Research Funding - AstraZeneca (Inst); Bristol Meyers Squib (Inst); Roche/Genentech (Inst)